metformin has been researched along with Deaf Mutism in 5 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the risk of hearing loss with regard to metformin exposure." | 8.31 | Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study. ( Tseng, CH, 2023) |
| "To compare the risk of hearing loss with regard to metformin exposure." | 4.31 | Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study. ( Tseng, CH, 2023) |
| "Metformin treatment will protect mice from noise-induced hearing loss (NIHL)." | 1.91 | Metformin Protects Against Noise-Induced Hearing Loss in Male Mice. ( Amanipour, R; Elkon, R; Hertzano, R; Kennedy, CL; Milon, B; Patel, P; Shuster, B, 2023) |
| "m." | 1.72 | Neurological manifestations in m.3243A>G-related disease triggered by metformin. ( Chan, KW; Ching, CK; Lam, SF; Lee, HH; Li, JK; Sheng, B; Tam, HV; Tong, HF; Tong, TT, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 4 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tong, HF | 1 |
| Lee, HH | 1 |
| Tong, TT | 1 |
| Lam, SF | 1 |
| Sheng, B | 1 |
| Chan, KW | 1 |
| Li, JK | 1 |
| Tam, HV | 1 |
| Ching, CK | 1 |
| Tseng, CH | 1 |
| Kennedy, CL | 1 |
| Shuster, B | 1 |
| Amanipour, R | 1 |
| Milon, B | 1 |
| Patel, P | 1 |
| Elkon, R | 1 |
| Hertzano, R | 1 |
| Kim, NH | 1 |
| Siddiqui, M | 1 |
| Vogel, J | 1 |
| Atabek, ME | 1 |
5 other studies available for metformin and Deaf Mutism
| Article | Year |
|---|---|
Neurological manifestations in m.3243A>G-related disease triggered by metformin.
Topics: Deafness; Diabetes Mellitus; DNA, Mitochondrial; Hearing Loss; Humans; MELAS Syndrome; Metformin | 2022 |
Metformin Reduces the Risk of Hearing Loss: A Retrospective Cohort Study.
Topics: Deafness; Diabetes Mellitus, Type 2; Hearing; Hearing Loss; Humans; Hypoglycemic Agents; Incidence; | 2023 |
Metformin Protects Against Noise-Induced Hearing Loss in Male Mice.
Topics: Animals; Cochlea; Deafness; Ear, Inner; Female; Hearing Loss, Noise-Induced; Male; Metformin; Mice; | 2023 |
MELAS Syndrome and MIDD Unmasked by Metformin Use: A Case Report.
Topics: Adult; Brain; Deafness; Diabetes Mellitus, Type 2; Diagnosis, Differential; Electroencephalography; | 2021 |
Re: "Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome", Sinha SK et al., JPEM 2007; 20: 1045-1052.
Topics: Child; Deafness; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; | 2008 |